Pfizer South Africa

Last updated: 14.07.2021


Company description

Pfizer in South Africa was established in 1953. Since then the company has been shaped by developments within the global Pfizer group, including the acquisition of Warner Lambert, Pharmacia and most recently, Wyeth.

Brian Daniel, CEO & Country Manager for Pfizer South Africa’s Biopharmaceutical Division, notes that the recent acquisition of Wyeth has proved particularly positive for the company, having broadened the spectrum of diseases that Pfizer is able to address. ‘Our offering now spans medication for pain, women’s health, cardio-vascular health, neuroscience and vaccines’, he enthuses.

The addition of a vaccine offering is of particular importance because it is in line with government’s aims to address infant mortality.

Products and services

Several of Pfizer’s medicine are world leaders in their therapeutic class.

Four of the company’s top ten products are world-leading pharmaceuticals discovered by scientists at the Pfizer discovery and development campus. These include medicines for treating high blood pressure and angina, the worlds best selling oral anti-fungal agent, a treatment for benign prostatic hypertrophy, and the first oral treatment for erectile dysfunction.

Research has concentrated recently on:

Diseases of the central nervous system
Metabolic diseases
Cardiovascular diseases
Inflammatory diseases (rheumatoid arthritis and osteo-arthritis)
Viral diseases (HIV/AIDS)
Allergies and respiratory diseases
Sexual health
Research is also undertaken to improve the health of both farm livestock and family pets.

Pfizer prescription-only medicines include anti-infectives treatments for cardiovascular diseases, depression and erectile dysfunction anti inflammatories, anti-epileptics and many others.



Address:85 Bute Rd, Sandown, Sandton, 2196, South Africa

Tel: 0860 734 937




We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here